Patent details

EP2826784 Title: Composition comprising a HCV NS3 protease inhibitor and a phosphoramidate prodrug of 2'-deoxy-2'-fluoro-2'-C-methyluridine nucleoside

Basic Information

Publication number:
EP2826784
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP141793588
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Composition comprising a HCV NS3 protease inhibitor and a phosphoramidate prodrug of 2'-deoxy-2'-fluoro-2'-C-methyluridine nucleoside
French Title of Invention:
Composition comprenant un inhibiteur de HCV NS3 protéase et un promédicament de phosphoramidate de 2'-deoxy-2'-fluoro-2'-C-methyluridine nucléoside
German Title of Invention:
Zusammensetzung enthaltend HCV NS3 Proteasehemmer und 2'-deoxy-2'-fluoro-2'-C-methyluridin-Nucleosid-Phosphoramidat-Prodrug
SPC Number:

Dates

Filing date:
26/03/2008
Grant date:
26/06/2019
EP Publication Date:
21/01/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/06/2019
EP B1 Publication Date:
26/06/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/03/2020
Expiration date:
26/03/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/06/2019
 
 

Name:
Gilead Pharmasset LLC
Address:
c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404, United States (US)

Inventor

1

Name:
Wang, Peiyuan
Address:
United States (US)

2

Name:
Du, Jinfa
Address:
United States (US)

3

Name:
Nagarathnam, Dhanapalan
Address:
United States (US)

4

Name:
Sofia, Michael Joseph
Address:
United States (US)

Priority

1

Priority Number:
909315 P
Priority Date:
30/03/2007
Priority Country:
United States (US)

2

Priority Number:
982309 P
Priority Date:
24/10/2007
Priority Country:
United States (US)

3

Priority Number:
53015
Priority Date:
21/03/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/7072; A61P 31/00; C07H 19/20;

Publication

European Patent Bulletin

Issue number:
201926
Publication date:
26/06/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages